HEPATO CELLULAR CARCINOMA (HCC)
Clinical trials for HEPATO CELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new HEPATO CELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for HEPATO CELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood pressure drug may boost liver cancer treatment
Disease control Recruiting nowThis study is testing whether adding a common blood pressure medication (nicardipine) to standard liver cancer treatment helps kill tumors more completely. Researchers want to see if this combination helps overcome the cancer's resistance to chemotherapy. The trial involves adult…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
Liver cancer patients test home recovery after treatment
Disease control Recruiting nowThis study is testing whether patients with primary liver cancer can safely receive their artery-based treatments and recover at home instead of staying in the hospital. It will compare patient satisfaction, safety, and costs between the two care approaches over seven months. The…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: NA • Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for liver cancer patients: major trial tests powerful drug combo
Disease control Recruiting nowThis study is testing whether adding standard chemotherapy to two newer cancer drugs helps people with advanced liver cancer live longer. Researchers will compare two treatment approaches in 326 patients who haven't had previous systemic treatment. The main goals are to see which…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE3 • Sponsor: Linhui Peng • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Poop transplant trial aims to rescue liver cancer treatment
Disease control Recruiting nowThis study is testing if a fecal microbiota transplant (FMT) can help patients with advanced liver cancer whose disease got worse while on standard drug therapy. Participants will receive the FMT and then restart the same cancer drugs to see if their response improves. The main g…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Simple blood test could spot liver cancer sooner
Diagnosis Recruiting nowThis study is testing a new blood test designed to detect liver cancer (hepatocellular carcinoma). Researchers will compare blood and tissue samples from 200 people—some with confirmed liver cancer and some with liver cirrhosis but no cancer. The goal is to see if the test can ac…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Sponsor: Epiliquid Holding, Inc • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC